Panayotis Constantinou
Datos Biográficos
| ID | 5539728 |
|---|---|
| NOMBRE | Panayotis Constantinou |
| NOMBRES | Panayotis |
| APELLIDO | Constantinou |
| FIRMA | CONSTANTINOU P |
| AFILIACIONES | l'Assurance Maladie |
| ORCID | 0000-0003-4023-5915 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2022 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Non-Covid-19 mortality among older people or with chronic conditions during year 2020 in France
Non-covid mortality was lower than expected during year 2020 among older people or with chronic conditions in France. Analyses during defined periods and analyses stratified by regions found significant excess non-covid mortality among specific groups of interest. Extending follow-up to years 2021 and 2022 is necessary to confirm non-covid excess mortality and assess the potential effect of healthcare underutilisation
Estimating years of life lost due to premature mortality at regional level in France in 2017, using a probabilistic redistribution approach
We quantified the full mortality burden for the first time in France at regional level, based on a new probabilistic redistribution method developed by researchers from Sciensano before COVID-19 pandemic. These estimates are important for future investigations on the contribution of social inequalities and risk factors to all-cause mortality in France with a focus on regional differences
The Economic Burden of Disease in France From the National Health Insurance Perspective
BACKGROUND: Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES: Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN: Annual cross-sectional study (2015-2019) based on the French national heal…
Sin obras prominentes en esta página.
The Economic Burden of Disease in France From the National Health Insurance Perspective
BACKGROUND: Identifying the most frequently treated and the costliest health conditions is essential for prioritizing actions to improve the resilience of health systems. OBJECTIVES: Healthcare Expenditures and Conditions Mapping describes the annual economic burden of 58 health conditions to prepare the French Social Security Funding Act and the Public Health Act. DESIGN: Annual cross-sectional study (2015-2019) based on the French national heal…
Non-Covid-19 mortality among older people or with chronic conditions during year 2020 in France
Non-covid mortality was lower than expected during year 2020 among older people or with chronic conditions in France. Analyses during defined periods and analyses stratified by regions found significant excess non-covid mortality among specific groups of interest. Extending follow-up to years 2021 and 2022 is necessary to confirm non-covid excess mortality and assess the potential effect of healthcare underutilisation
Estimating years of life lost due to premature mortality at regional level in France in 2017, using a probabilistic redistribution approach
We quantified the full mortality burden for the first time in France at regional level, based on a new probabilistic redistribution method developed by researchers from Sciensano before COVID-19 pandemic. These estimates are important for future investigations on the contribution of social inequalities and risk factors to all-cause mortality in France with a focus on regional differences
Environmental health (3 obras) · Medicine (3 obras) · Public health (3 obras) · Biostatistics (2 obras) · Demography (2 obras) · Demography (2 obras) · Disease (2 obras) · Epidemiology (2 obras) · Global Health Care Issues (2 obras) · Climate Change and Health Impacts (1 obras)